Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor

References

1. Bergelson J. M., Shepley M. P., Chan B. M., Hemler M. E., Finberg R. W. 1992; Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255:1718–1720
   [Google Scholar]
2. Bergelson J. M., St John N., Kawaguchi S., Chan M., Stubdal H., Moldin J., Finberg R. W. 1993; Infection by echovirus 1 and 8 depends on the alpha-2 subunit of human VLA-2. Journal of Virology 67:6847–6852
   [Google Scholar]
3. Bergelson J. M., Chan M., Solomon K. R., St John N. F., Lin H., Finberg R. W. 1994; Decay -accelerating factor (CD55), a glycosyl- phosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proceedings of the National Academy of Sciences, USA 91:6245–6249
   [Google Scholar]
4. Bergelson J. M., Mohanty J. G., Crowell R. L., St John N. F., Lublin D. M., Finberg R. W. 1995; Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). Journal of Virology 69:1903–1906
   [Google Scholar]
5. Bergelson J. M., Cunningham J. A., Droguett G., KurtJones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W. 1997; Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323
   [Google Scholar]
6. Berinstein A., Roivainen M., Hovi T., Mason P. W., Baxt B. 1995; Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. Journal of Virology 69:2664–2666
   [Google Scholar]
7. Clarkson N. A., Kaufman R., Lublin D. M., Ward T., Pipkin P. A., Minor P. D., Evans D. J., Almond J. W. 1995; Characterization of the echovirus-7 receptor - domains of cd55 critical for virus binding. Journal of Virology 69:5497–5501
   [Google Scholar]
8. Cova L., Aymard L. 1980; Isolation and characterization of non- haemagglutinating echovirus 11. Journalof General Virology 51:219–222
   [Google Scholar]
9. Daniels G. L., Green C. A., Powell M. R. 1997; Cromer antibodies: analysis with soluble recombinant decay-accelerating factor (srDAF) and the monoclonal antibody immobilization of erythrocyte antigens assay (MAIEA). Transfusion 37:S351
   [Google Scholar]
10. Davitz M. A., Low M. G., Nussenzweig V. 1986; Release of decay- accelerating factor (daf) from the cell-membrane by phosphatidylinositol- specific phospholipase-c (piplc) - selective modification of a complement regulatory protein. Journal of Experimental Medicine 163:1150–1161
    [Google Scholar]
11. Everaert L., Vrijsen R., Boeye A. 1989; Eclipse products of poliovirus after cold-synchronized infection of HeLa cells. Virology 171:76–82
    [Google Scholar]
12. Holland J. J. 1962; Irreversible eclipse of poliovirus by HeLa cells. Virology 16:163–176
    [Google Scholar]
13. Jackson T., Ellard F. M., Ghazaleh R. A., Brookes S. M., Blakemore W. E., Corteyn A. H., Stuart D. I., Newman J. W., King A. M. Q. 1996; Efficient infection of cells in culture by type-O foot-and-mouth- disease-virus requires binding to cell-surface heparan-sulfate. Journal of Virology 70:5282–5287
    [Google Scholar]
14. Kaplan G., Freistadt M. S., Racaniello V. R. 1990; Neutralization of poliovirus by cell receptors expressed in insect cells. Journal of Virology 64:4697–4702
    [Google Scholar]
15. Karnauchow T. M., Tolson D. L., Harrison B. A., Altman E., Lublin D. M., Dimock K. 1996; The HeLa cell receptor for enterovirus 70 is decay accelerating factor (CD55). Journal of Virology 70:5143–5152
    [Google Scholar]
16. Lublin D. M., Atkinson J. P. 1989; Decay -accelerating factor: biochemistry, molecular biology, and function. Annual Review of Immunology 7:35–58
    [Google Scholar]
17. Melnick J. L. 1990; Polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In Virology Fields B. N., Knipe D. M. Edited by New York: Raven Press;
    [Google Scholar]
18. Powell R. M., Ward T., Evans D. J., Almond J. W. 1997; Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation. Journal of Virology 71:9306–9312
    [Google Scholar]
19. Reagan K. J., Goldberg B., Crowell R. L. 1984; Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. Journal of Virology 49:635–640
    [Google Scholar]
20. Shafren D. R., Bates R. C., Agrez M. V., Herd R. L., Burns G. F., Barry R. D. 1995; Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. Journal of Virology 69:3873–3877
    [Google Scholar]
21. Shafren D. R., Dorahy D. J., Ingham R. A., Burns G. F., Barry R. D. 1997a; Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. Journal of Virology 71:4736–4743
    [Google Scholar]
22. Shafren D. R., Williams D. T., Barry R. D. 1997b; A decay- accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. Journal of Virology 71:9844–9848
    [Google Scholar]
23. Ward T., Pipkin P. A., Clarkson N. A., Stone D. M., Minor P. D., Almond J. W. 1994; Decay accelerating factor (CD55) identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO Journal 13:5070–5074
    [Google Scholar]